Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats-Reference-Cited by-同舟云学术

Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats

Published:1997-12 Issue:8 Volume:122 Page:1687-1693
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Gardiner S M.,Kemp P A.,Brunner-Ferber F.,Bennett T.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0701550/fullpdf

Reference23 articles.

1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril;BRALET;J. Pharmacol. Exp. Ther.,1994

2. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones;ERDÖS;FASEB J.,1989

3. Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11;FLYNN;J. Med. Chem.,1993

4. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension;FOURNIE-ZALUSKI;J. Med. Chem.,1994

5. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension;FRENCH;J. Cardiovasc. Pharmacol.,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver;British Journal of Pharmacology;2010-02

2. Dual ACE and NEP Inhibitors: A Review of the Pharmacological Properties of MDL 100,240;Cardiovascular Drug Reviews;2006-06-07

3. Optimizing Dose Selection with Modeling and Simulation: Application to the Vasopeptidase Inhibitor M100240;The Journal of Clinical Pharmacology;2004-06

4. Cardiorenal Protective Effects of Vasopeptidase Inhibition with Omapatrilat in Hypertensive Transgenic (mREN‐2)27 Rats;Clinical and Experimental Hypertension;2004-01

5. Pharmacological modulation of the natriuretic peptide system;Expert Opinion on Therapeutic Patents;2003-09